$25.34
▼ -0.0% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Are You Looking for a Top Momentum Pick? Why Elanco Animal Health Incorporated (ELAN) is a Great Choice
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
Overview
52-week range
$13
$28
84% of range
Avg surprise (last 3)
+22.3%
Avg reaction (last 2)
+20.1%
100% positive
Latest IV / EM
57%
EM ±13.1% · $25 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.40 | $0.34 | +17.6% | +8.1% | +13.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.07 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.26 | $0.20 | +30.0% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.37 | $0.31 | +19.4% | — | +26.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.73 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.10 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.06 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-2.22 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.20 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | BMO | $0.27 | $0.26 | +3.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37B | — | $1.14B | $1.24B | $1.19B | — | $1.03B | $1.18B |
| Cost of revenue | $586M | — | $530M | $528M | $509M | — | $492M | $495M |
| Gross profit | $785M | — | $607M | $713M | $684M | — | $538M | $689M |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $57M | — | $-34M | $11M | $67M | — | $364M | $-50M |
| EPS (diluted) | $0.11 | — | $-0.07 | $0.02 | $0.13 | — | $0.73 | $-0.10 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $428M | $545M | $505M | $539M | $487M | $468M | $490M | $416M |
| Inventory | $1.72B | $1.74B | $1.71B | $1.67B | $1.59B | $1.57B | $1.63B | $1.61B |
| Total current assets | $3.58B | $3.46B | $3.49B | $3.61B | $3.44B | $3.21B | $3.37B | $4.01B |
| Total assets | $13.22B | $13.36B | $13.55B | $13.74B | $12.94B | $12.61B | $13.28B | $13.76B |
| Long-term debt | — | — | — | — | $4.35B | $4.28B | $4.31B | $5.46B |
| Total liabilities | $6.72B | $6.81B | $6.80B | $6.97B | $6.59B | $6.52B | $6.76B | $7.82B |
| Total equity | $6.50B | $6.55B | $6.75B | $6.78B | $6.35B | $6.10B | $6.52B | $5.94B |